CrushSCI reveals real review times for each journal, giving authors transparent guidance for submission. As AI makes publishing increasingly challenging, the platform helps authors improve submission efficiency. Contact us if you need assistance.
Medicine
Medicine
Back to journal directory
Review Cycle Records
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
Paper Review Records
All Paper Review Records
5 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
67
days
Optimized LC-MS/MS quantification of tuberculosis drug candidate macozinone (PBTZ169), its dearomatized Meisenheimer Complex and other metabolites, in human plasma and urine
Authors
Vincent Desfontaine; Sylvie Guinchard; Sara Marques; Anthony Vocat; Farizade Moulfi; François Versace; Jeff Huser-Pitteloud; Anton Ivanyuk; Carine Bardinet; Vadim Makarov; Olga Ryabova; Pascal André; Sylvain Prod'Hom; Haithem Chtioui; Thierry Buclin; Stewart T. Cole; Laurent DecosterdShow moreShow less
Affiliations
1. Laboratory & Service of Clinical Pharmacology, Department of Laboratory Medicine and Pathology, University Hospital of Lausanne and University of Lausanne, Switzerland; 2. Global Health Institute, School of Life Sciences, EPFL, Lausanne, Switzerland; 3. Innovative Medicines for Tuberculosis (IM4TB), Lausanne, Switzerland; 4. Federal Research Center “Fundamentals of Biotechnology RAS”, Moscow, RussiaShow moreShow less
47
days
A fast, efficient, and scalable method for purifying recombinant SARS-CoV-2 spike protein
Authors
Nikhila Butani; Yating Xu; Si Pan; Yves Durocher; Raja GhoshShow moreShow less
Affiliations
1. Department of Chemical Engineering, McMaster University, Hamilton, ON L8S 4L7, Canada; 2. National Research Council of Canada, Montreal, QC H4P 2R2, Canada; 3. Département de biochimie et médecine moléculaire, Faculté de médecine, Université de Montréal, Montreal, QC H3C 3J7, CanadaShow moreShow less
161
days
HPLC-DAD quantification of favipiravir in whole blood after extraction from volumetric absorptive microsampling devices
Authors
Cahaya Azzahra Rahmadhani; Yahdiana Harahap; Tesia Aisyah RahmaniaShow moreShow less
Affiliations
1. Laboratory of Bioavailability/Bioequivalence, Faculty of Pharmacy, Universitas Indonesia, Depok, Indonesia; 2. Laboratory of Pharmaceutical Chemistry, Faculty of Military Pharmacy, Republic of Indonesia Defense University, Bogor, IndonesiaShow moreShow less
62
days
Validation and application of a quantitative LC-MS/MS assay for the analysis of first-line anti-tuberculosis drugs, rifabutin and their metabolites in human breast milk
Authors
Phiwe Zuma; Anton Joubert; Marthinus van der Merwe; Jennifer Norman; Catriona Waitt; Richard Court; Marian Loveday; Sandra Castel; Lubbe WiesnerShow moreShow less
Affiliations
1. Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa; 2. Department of Pharmacology and Therapeutics, University of Liverpool, UK; 3. HIV and other Infectious Diseases Research Unit, South African Medical Research Council, KwaZulu-Natal, South Africa; 4. CAPRISA-MRC HIV-TB Pathogenesis and Treatment Research Unit, University of KwaZulu-Natal, South AfricaShow moreShow less
78
days
Enabling online determination of the size-dependent RNA content of lipid nanoparticle-based RNA formulations
Authors
Xiujuan Jia; Yong Liu; Angela M. Wagner; Michelle Chen; Yuejie Zhao; Katelyn J. Smith; Dan Some; Andreas M. Abend; Justin PenningtonShow moreShow less
Affiliations
1. Analytical Sciences, Analytical Research and Development, MRL, Merck & CO., Inc., Rahway, NJ, USA; 2. Sterile and Specialty Products, Pharmaceutical Sciences, MRL, Merck & CO., Inc., Kenilworth, NJ, USA; 3. Wyatt Technology Corporation, Goleta, CA, USA; 4. Preformulation, Analytical Research and Development, MRL, Merck & CO., Inc., Kenilworth, NJ, USAShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days